The effects of in vivo administration of endotoxin on the functions and interaction of hepatocytes and Kupffer cells.
It was the purpose of this study to determine the effects of the in vivo administration of endotoxin on certain in vitro hepatocyte and Kupffer cell functions. An Alzet osmotic pump that contained endotoxin (LPS, 2.5 mg/100g) was implanted into the peritoneal cavity of 300g guinea pigs and delivered the endotoxin over a period of four days. In vivo administration of LPS did not cause a change in the in vitro release of albumin by isolated hepatocytes. However, when hepatocytes were co-cultured with Kupffer cells there was a significant decrease in albumin release for both control and LPS-treated animals. There was no difference between control and LPS-treated animals in the release of C3 by hepatocytes. However, there was a significant increase over the control group in C3 release by Kupffer cells from LPS-treated animals. When hepatocytes and Kupffer cells were cultured together, their release of C3 was not additive. Kupffer cells from LPS-treated animals released significantly greater amounts of PGE2 than control animals when stimulated in vitro with LPS. Thus, these Kupffer cells appeared to be primed to respond to an in vitro challenge of LPS. Kupffer cells from LPS-treated animals had significantly depressed antibody dependent cellular cytotoxicity (ADCC). This endotoxin model is useful for determining the in vivo effects of endotoxin on cellular function and gives some indirect evidence for the detrimental effects of LPS on the immune system and host defense.
Ogle
C K
CK
Shriners Burns Institute, Cincinnati, OH 45219.
Wu
J Z
JZ
Alexander
J W
JW
Fischer
J E
JE
Ogle
J D
JD
D000818:Animals; D002450:Cell Communication / Q000187:drug effects; D002478:Cells, Cultured; D003176:Complement C3 / Q000096:biosynthesis; D015232:Dinoprostone / Q000378:metabolism*; D004731:Endotoxins / Q000494:pharmacology*; D004926:Escherichia coli; D006168:Guinea Pigs; D007700:Kinetics; D007728:Kupffer Cells / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D008297:Male; D012016:Reference Values; D012709:Serum Albumin / Q000096:biosynthesis / Q000302:isolation & purification
D003176:Complement C3; D004731:Endotoxins; D008070:Lipopolysaccharides; D012709:Serum Albumin; D015232:Dinoprostone